SCHEMBL31470342

SCHEMBL31470342

CN(C)C(=O)C1=NOC2(CCCN(C(=O)OC(C)(C)C)CC2)C1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 5/20 0.50
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
HPGD P15428 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PKM P14618 1/20 0.36
MAPT P10636 2/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31470380 0.88 GPR119 (0.53) GPR119USP2SMN1; SMN2HPGDMEN1
SCHEMBL26289064 0.84 GPR119 (0.47) GPR119USP2SMN1; SMN2HPGDMEN1
SCHEMBL1639199 0.83 GPR119 (0.57) GPR119USP2SMN1; SMN2MAPTTP53
SCHEMBL31470348 0.82 GPR119 (0.48) GPR119USP2SMN1; SMN2MEN1KMT2A
SCHEMBL12901476 0.81 GPR119 (0.46) GPR119USP2SMN1; SMN2HPGDMEN1
SCHEMBL12901475 0.81 GPR119 (0.46) GPR119USP2SMN1; SMN2HPGDMEN1
SCHEMBL12901443 0.81 GPR119 (0.46) GPR119USP2SMN1; SMN2HPGDMEN1
SCHEMBL25383112 0.80 GPR119 (0.46) GPR119USP2SMN1; SMN2HPGDMEN1
SCHEMBL13811458 0.80 GPR119 (0.57) GPR119USP2SMN1; SMN2JAK2JAK1
SCHEMBL13170189 0.79 GPR119 (0.50) GPR119USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025077770-A1 FUSED RING COMPOUND AND USE THEREOF IN KRAS INHIBITOR 成都海博为药业有限公司 2025-04-17 WO disclosed